Inactive Instrument

20/20 GeneSystems Inc. Share Price

Equities

Duration

Period

Style

20/20 GeneSystems Inc. announced that it expects to receive $4.999995 million in funding	14/08/22	CI
20/20 GeneSystems, Inc. Launches First Accelerator Facility for Innovative Clinical Lab Tests	28/09/21	CI
20/20 GeneSystems, Inc. announced that it has received $2 million in funding	03/02/16	CI
20/20 GeneSystems, Inc. announced that it expects to receive $3 million in funding.	27/01/16	CI
20/20 GeneSystems, Inc. announced that it has received $4.5 million in funding from Ping An Ventures and other investors.	13/01/16	CI
20/20 GeneSystems, Inc. announced that it expects to receive $4 million in funding from Ping An Ventures.	30/10/14	CI
20/20 GeneSystems Inc. announced that it has received funding from BHC Center Of Financial & Investment Business LLC	17/08/14	CI

Managers	Title	Age	Since
Jonathan Cohen CEO	Chief Executive Officer	-	31/12/07
Nora Li PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Richard Cohen BRD	Director/Board Member	73	31/12/15
Jonathan Cohen CEO	Chief Executive Officer	-	31/12/07
John Compton BRD	Director/Board Member	-	-

Sector